Design and in vitro evaluation of chlorpheniramine maleate from different eudragit based matrix patches: Effect of platicizer and chemical enhancers

Authors

  • R Rajan
  • N.D. Sheba Rani
  • G. Kajal
  • D Sanjoy Kumar
  • K Jasmina
  • N Arunabha

Keywords:

Matrix patch, Chlorpheniramine maleate, Chemical enhancers, Dibutyl phthalate, Eudragit polymer, Polyvinylpyrrolidone

Abstract

The release and permeation studies were carried out for developing transdermal therapeutic systems with chlorpheniramine maleate (CPM). The patches were prepared with eudragit RS-100 and RL-100 with/without polyvinyl pyrrolidone (PVP) and dibutyl phthalate (DBP) in different compositions. Thickness, tensile strength, drug content, moisture content and water absorption studies of the patches were measured. In vitro release/permeation of CPM was studied in modified Keshary-Chien diffusion cell. Chemical enhancers like l-menthol, oleic acid and phospholipon80 were added to compare the release pattern of the drug. The percent release of the drug from matrix patch increased with increase of PVP & DBP but the tensile strength decreased with the increase of DBP & PVP. Experimental release/permeation data of different formulations of the matrix systems are reported. Also the drug-polymer interaction was investigated by ATR-FTIR studies. The discussion was correlated the efficient matrix dispersion patch from suitable eudragit polymers for transdermal antihistamine applications in film device industry.

Downloads

References

Ritschel WA, Udeshi. Drug release mechanisms from matrix and barrier coated tablets prepared with acrylic resin, with and without addition of chanelling agent. Pharm Ind 1987; 49:734-739.

Aqil M, Ali A. Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation. Eur J Pharm & Biopharm 2002; 54(2): 161-164.

Aqil M, Sultana Y, Ali A. Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pham 2003; 53:119- 125.

Verma PRP, Sunil SI. Transdermal delivery of propranolol using mixed grades of Eudragit: Design and in vitro and in vivo Evaluation. Drug Dev & Ind Pharm 2000; 26 (4): 471-476.

Jain SK, Chourasia MK, Sabitha M, Jain R, Ashawat M. Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Delivery 2003; 10: 169-177.

Kanikannan N, Andega S, Burton S, Babu RJ, Mandip Singh. Formulation and In vitro evaluation of transdermal patches of melatonin. Drug Dev & Ind Pharm 2004; 30 (2): 205-212.

Lin SY, Lee CJ, Lin YY. Drug – polymer interaction affecting the mechanical properties, adhesion strength and release kinetics of piroxicam – loaded Eudragit E films plasticized with different plasticizers. J. Controlled release 1995; 33 (3):375-381.

Rosen SL. Fundamental principles of polymeric materials, 2nd ed. New York: John Wiley & Sons, New York, 1993.

Rahman M, Christopher SB. The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges. Prog Polym Sci 2004; 29:1223–1248.

Repka MA, Gerding TG, Repka SL, McGinity JW. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev & Ind Pharm 1999; 25(5):625-33.

Michael AR, James WM. Influence of Chlorpheniramine Maleate on Topical Hydroxypropylcellulose Films Produced by Hot-Melt Extrusion. Pharmaceutical Development and Technology 2001; 6(3): 297–304.

Andronis V, Mesiha MS, Plakogiannis FM. Design and evaluation of transdermal chlorpheniramine maleate drug delivery system. Pharm Acta Helv 1995; 70:301–306.

Jen-Taut Yeh, Chin-Lai Chen, Huang KS, Nien YH, Chen JL, Huang PZ. Synthesis, Characterization, and Application of PVP/Chitosan Blended Polymers. Journal of Applied Polymer Science 2006; 101(2): 885 – 891.

Dae-Joon Kim, Seok Il Park, Myung-Hyun Lee. Tensile strength of aqueous-based alumina tapes using a PVP–PVA–gelatin cobinder. Ceramics International 2005; 31(4): 577-581.

Manning SC, Moore RB. Reactive Compatibilization of Polypropylene and Polyamide– 6, 6 with Carboxylated and Maleated Polypropylene”. Polymer Engineering and Science 1999; 39(10):1921 - 1926.

Shan-Yang Lin, Ko-Shao Chen, Liang Run-Chu. Organic esters of plasticizers affecting the water absorption, adhesive property, glass transition temperature and plasticizer permanence of Eudragit acrylic films. Journal of Controlled Release 2000 ; 68 :343–350.

Mi FL, Shyu SS, Wu YB, Lee ST, Shyong JY, Huang RN. Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials 2001; 22: 165–173.

Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, Hao JY. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002; 59: 438–449.

Mi FL, Wu YB, Shyu SS, Chao AC, Lai JY, Su CC. Asymmetric chitosan membranes prepared by dry/wet phase separation: a new type of wound dressing for controlled antibacterial release. J Membr Sci 2003; 212: 237–254.

Jenquin MR, Liebowitz SM, Sarabia RE, McGinity JW. Physical and chemical factors influencing the release of drugs from acrylic resin films. J Pharm Sci 1990; 79:811–816.

Jenquin MR, Sarabia RE, Liebowitz SM, McGinity JW. Relationship of film properties to drug release from monolithic films containing adjuvants. J Pharm Sci 1992; 81:983–989.

Paulo Costa, José Manuel Sousa Lobo. Modeling and comparison of dissolution profiles. European J Pharm Sci 2001 ; 13 (2) :123-133.

Tojo K, Valia KH, Chotani G, Chien YW. Long-term permeation kinetics of estradiol IV. A theoretical approach to simultaneous skin permeation and bioconversion of estradiol esters. Drug Dev Ind Pharm 1985; 11(6): 1175-1193.

Lehmann K. Coating of Multiparticulates Using Polymeric Solutions. In: I. Ghebre-Sellassie, Editor, Multiparticulate Oral Drug Delivery, Marcel Dekker, Inc, New York ;1994: 51–78.

Lehmann K. Chemistry and Application Properties of Polymethacrylate Coating Systems. In: McGinity JW, Editor, Aqueous Polymeric Coating for Pharmaceutical Dosage Forms, Marcel Dekker, Inc, New York; 1998:153–246.

Patel VM, Prajapati BG, Patel MM. Effect of Hydrophilic Polymers on Buccoadhesive Eudragit Patches of Propranolol Hydrochloride Using Factorial Design. AAPS PharmSciTech. 2007; 8(2): 45.

Shan-Yang Lin, Chau-Jen Lee, Yih-Yih Lin. The Effect of Plasticizers on Compatibility, Mechanical Properties, and Adhesion Strength of Drug-Free Eudragit E Films. Pharm Res 1991; 8(9):1137-43.

Adrian CW, Brian WB. Penetration enhancers Advanced Drug Delivery Reviews 2004;56 : 603– 618

Williams Barry, Williams AC, Barry BW. Terpenes and the lipid–protein partitioning theory of skin penetration enhancement. Pharm Res 1991; 8:17–21.

Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci 1997; 86:1369–1373.

Emmanuelle Corbe Guillard, Ali Tfayli, Cécile Laugel, Arlette Baillet-Guffroy. Molecular interactions of penetration enhancers within ceramides organization: A FTIR approach. Eur journal of pharm sci 2009; 36: 192-199.

Downloads

Published

2009-03-20

How to Cite

1.
Rajan R, Sheba Rani N, Kajal G, Sanjoy Kumar D, Jasmina K, Arunabha N. Design and in vitro evaluation of chlorpheniramine maleate from different eudragit based matrix patches: Effect of platicizer and chemical enhancers. Ars Pharm [Internet]. 2009 Mar. 20 [cited 2025 May 18];50(4):177-94. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/4899

Issue

Vol. 50 No. 4 (2009)

Section

Original Articles

License

The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:

  1. The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.

b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.

c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).